01 5Alphagan/Combigan
02 2Xalabrands
Main Therapeutic Indication : Ophthalmology
Currency : USD
2020 Revenue in Millions : 326
2019 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Ophthalmology
Currency : USD
2021 Revenue in Millions : 529
2020 Revenue in Millions : 326
Growth (%) : 62
Main Therapeutic Indication : Ophthalmology
Currency : USD
2022 Revenue in Millions : 346
2021 Revenue in Millions : 529
Growth (%) : -35
Main Therapeutic Indication : Ophthalmology
Currency : USD
2023 Revenue in Millions : 272
2022 Revenue in Millions : 346
Growth (%) : -21
Main Therapeutic Indication : Ophthalmology
Currency : USD
2019 Revenue in Millions : 522
2018 Revenue in Millions : 551
Growth (%) : -5
Main Therapeutic Indication : Ophthalmology
Currency : USD
2022 Revenue in Millions : 195
2021 Revenue in Millions : 226
Growth (%) : -14
Main Therapeutic Indication : Ophthalmology
Currency : USD
2023 Revenue in Millions : 193
2022 Revenue in Millions : 195
Growth (%) : -1
LOOKING FOR A SUPPLIER?